Effects of gabapentin enacarbil on restless legs syndrome and leg pain in dementia with L ewy bodies

Restless legs syndrome ( RLS ) is a common neurological disorder. Dementia with L ewy bodies ( DLB ) is the second most common form of neurodegenerative dementia after A lzheimer's disease. Both RLS and DLB can be effectively treated by dopaminergic medications, suggesting the role of dopamine dysfunction in the pathogenesis of both diseases. Here, I report on a J apanese woman with probable DLB and RLS who was treated with gabapentin enacarbil, a non‐dopaminergic agent. Because a dopamine agonist, a first‐line therapy for moderate to severe RLS , caused the occurrence of metamorphopsia, an alternative treatment of gabapentin enacarbil was used; this treatment improved the patient's RLS without worsening her psychiatric symptoms. An alternative treatment is desirable for DLB patients with RLS because they often experience intolerable side‐effects with a dopamine agonist, especially visual hallucinations. Administering gabapentin enacarbil also improved the continuous leg pain that occurred in conjunction with the development of RLS . Although the neurobiological mechanism in the development of pain remains unclear, a range of non‐dopaminergic structures likely mediated pain processing in DLB in the present case based on neuropharmacological results. This is the first report reporting the effects of gabapentin enacarbil for RLS and leg pain in a DLB patient with psychiatric symptoms.